We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Brazil's drug regulator, Anvisa, has issued new guidance on the safety
of Cox-2 inhibitors, effectively reversing its decision to withdraw the drugs
last year.
The Indian affiliate of UK-based drug major GlaxoSmithKline, GSK
India, has announced plans to begin vaccines production in the country at a
new facility by early 2006.
Indonesian drugmaker Indofarma has forecast that sales could reach
IDR700bn (US$77.7mn) this year, with generic medicines accounting for up to
80% of revenue.
Israeli pharmaceutical manufacturers have expressed concern that
the Israeli government's new data exclusivity bill, scheduled to be included
as a rider to the country's 2005 budget, will represent a surrender to US drug
industry interests.
The head of the Mexican Institute of Industrial Property has complained
that the present pace of intellectual property reform in the country has done
little to avert wide-scale copying of patented goods.
The pharmaceuticals arm of Australian healthcare and generic drug
company Mayne Group has announced a EUR21mn (US$27.73mn) development deal with
Croatia's Pliva.